ContextVision CONTX.OL · NOK

Its shares trade on Oslo Børs under the ticker CONTX.OL. It has been listed since 6 March 1997. In the fiscal year to 31 December 2025, it reported revenue of SEK 110.3m and net income of SEK 787,000. At that date it held total assets of SEK 124.9m and shareholders' equity of SEK 92.2m.

ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm. The firm's products are tailored primarily for medical imaging equipment manufacturers. Its product portfolio is structured into six groups, namely Mammography, comprising such products, as GOPView MAMMO, MAMMO PLUSViev and C-CAD; Ultrasound, comprising the US PlusView family of products, GOPView USXI and GOPiCE US products; Magnetic Resonance Imagining (MRI), comprising the GOPView MRI2 product; Computer tomography (CT), comprising the GOPView CT software; Digital X-Ray, comprising such products, as GOPView XR2 and GOPView XR2-DI, among others, and Interventional Radiology/Fluoroscopy, comprising the GOPView IRV Plus and GOPView IRV Ultra products. As of December 31, 2011, the Company had one wholly owned subsidiary, ContextVision Inc, based in the United States.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Olof SandenIndependent Chairman of the BoardSEK 385,000
• Mr. Gerald PotzschChief Executive OfficerSEK 3.4m
• Mr. Richard HallstroemChief Financial Officer
• Mr. Gunnar LaethenChief Technology Officer
• Ms. Katarina FloodChief Service Officer
• Mr. Ola LindbladChief Sales and Solution Officer, since 2023SEK 1.3m
• Mr. Sven Guenther-HanssenDirector, since 2011SEK 253,000
• Mr. Martin HedlundDirector, since 1997SEK 253,000
• Mr. Martin IngvarIndependent DirectorSEK 253,000

Overall

26

Environment

15

Social

34

Governance

30

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.